Blocking of beta-adrenoceptors in arterial hypertension
Aramendia, P.
Medicina 40(4): 467-477
1980
ISSN/ISBN: 0025-7680 PMID: 6111016 Document Number: 156292
Document emailed within 1 workday
Related Documents
Nakamura, T.; Hosohata, Y.; Hosohata, K.; Hattori, K.; Suzuki, J.; Nagatomo, T. 1999: Relationship between hydrophobicity and beta-blocking potencies, affinities or dissociation of beta-blockers from beta-adrenoceptors Research Communications in Molecular Pathology and Pharmacology 106(3): 203-211Cerasola, G.A.; Botta, R.M.; Riolo, A.; Amico, L.M. 1979: Efficacy of a new beta-blocking drug (atenolol, ICi 66082) in treating arterial hypertension Bollettino Della Societa Italiana di Cardiologia 24(5): 493-500
Metelitsa, V.I.; Filatova, N.P. 1990: Role of a beta adrenergic blocking agent nadolol (corgard) in prevention of arterial hypertension: a 6-month treatment (cooperative study) Kardiologiia 30(5): 8-14
Ishihata, A.; Kushida, H.; Endoh, M. 1988: Enantiomers of dobutamine increase the force of contraction via beta adrenoceptors, but antagonize competitively the positive inotropic effect mediated by alpha-1 adrenoceptors in the rabbit ventricular myocardium Journal of Pharmacology and Experimental Therapeutics 246(3): 1080-1087
Lorimer, A.R.; Jones, J.V.; Clark, B.; Dunn, F.G.; Melville, D.; Lawrie, T.D. 1976: Indications for beta-adrenoceptor blocking drugs in hypertension Postgraduate Medical Journal 52(Suppl 4): 81-85
Hansson, L.; Henningsen, N.C.; Jameson, S.; Karlberg, B.E.; Westerlund, A.; Aberg, H. 1976: Clinical testing of a new beta blocking agent--atenolol--in hypertension Lakartidningen 73(34): 2741-2744
Klevans, L.R.; Kovacs, J.L.; Kelly, R. 1976: Central effect of beta adrenergic blocking agents on arterial blood pressure Journal of Pharmacology and Experimental Therapeutics 196(2): 389-395
Lydtin, H. 1975: The significance of beta-adrenergic receptor blocking agents in the treatment of hypertension Die Medizinische Welt 6(35): 1487-1492
Cascone, A.; Ferrari, F.; Alaimo, A.; Daprati, A.; Cascone, G. 1985: Treatment of arterial hypertension with a calcium-channel blocking agent, nicardipine hydrochloride Bollettino Chimico Farmaceutico 124(5): 37S-42S
Lenders, J.W.; Thien, T. 1984: Cold hands and feet in the treatment of hypertension with beta receptor blocking agents Nederlands Tijdschrift Voor Geneeskunde 128(49): 2318-2321
Lopes, H.F.; Silva, H.B.; Bellotti, G.; Pillegi, F. 1990: Efficacy and tolerance of a new calcium-channel blocking agent (nitrendipine) in the treatment of arterial hypertension Arquivos Brasileiros de Cardiologia 54(3): 227-229
Shen, J.Q. 1981: Atenolol, a new beta-adrenergic blocking agent, in treatment of hypertension: therapeutic effect and hemodynamic changes Zhonghua Xin Xue Guan Bing Za Zhi 9(2): 94-98
Frick, M.H.; Hartikainen, M.; Pörsti, P. 1978: Penbutolol, a new non-selective beta-adrenergic blocking compound in the treatment of hypertension. A comparision with propranolol Annals of Clinical Research 10(2): 105-106
England, J.D. 1981: Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol Australian and New Zealand Journal of Medicine 11(1): 35-40
Rahn, K.H. 1980: The influence of beta receptor blocking drugs on plasma catecholamine levels in patients with essential hypertension Archives Internationales de Pharmacodynamie et de Therapie Suppl: 54-57
Schulte, K.L.; Meyer-Sabellek, W.; Thiede, H.M.; Röcker, L.; Gotzen, R. 1987: Beta-adrenoceptor stimulating and blocking agents in essential hypertension: single and combined therapy with terbutaline and metoprolol International Journal of Clinical Pharmacology Therapy and Toxicology 25(10): 539-544
Hoffmann, J.; Schrey, A.; Grund, R.; Forst, T. 1981: Combination of beta-receptor blocking agents and saluretica in outpatient treatment of hypertension. Results of a comparative study Münchener Medizinische Wochenschrift 123(12): 483-488
Rostan, A. 1978: Effects of tolamolol and bufuralol on the arterial blood pressure and plasma renin activity. Contribution to the study of beta-blocking agents action mechanisms Schweizerische Rundschau für Medizin Praxis 67(1): 27-35
Erina, E.V.; Charyev, K.E.; Oshchepkova, E.V. 1983: Therapeutic effect of the cardioselective beta-blocking agent tenormin and its action on the indices of systemic, intracardiac and regional hemodynamics in patients with hypertension Kardiologiia 23(4): 53-59
Yamamoto, N.; Nomura, M.; Okubo, K.; Maeda, K.; Goto, T. 1999: Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent Journal of Cardiovascular Pharmacology 33(4): 587-594